US HB2408 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 30 2023 - 25% progression, died in committee
Action: 2023-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 30 2023 - 25% progression, died in committee
Action: 2023-04-07 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to provide a review process for adverse national coverage determinations with respect to drug coverage under the Medicare program.
Title
Access to Innovative Treatments Act of 2023
Sponsors
| Rep. Nanette Barragan [D-CA] | Rep. John Joyce [R-PA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-04-07 | House | Referred to the Subcommittee on Health. |
| 2023-03-30 | House | Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-03-30 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/2408/all-info |
| Text | https://www.congress.gov/118/bills/hr2408/BILLS-118hr2408ih.pdf |
